Philipp Boder, PhD, is a Senior Commercial Scientist at AMSBIO since January 2025 and has previously worked as a Senior Cell Biologist at Arctoris, focusing on AI-driven drug discovery through cell-based and automated assay development. Philipp completed a PhD in Cardiovascular Science at the University of Glasgow, supported by the British Heart Foundation, after earning an MRes in Translational Medicine. Swapping biological insights, Philipp received the Royal Society of Edinburgh Saltire Early Career Fellowship for research on kidney organoids at the Institute for Bioengineering of Catalonia. Philipp has held editorial and writing roles, including Chief Editor of Young European Biologists, alongside extensive hands-on experience in various molecular and cellular biology techniques throughout an academic trajectory that began with a Bachelor's degree in Molecular and Cellular Biology.
This person is not in the org chart
This person is not in any teams